Calorie or carbohydrate restriction
AOD-9604 (Advanced Obesity Drug) is a synthetic peptide consisting of 16 amino acids that represents a modified fragment of the C-terminal region of human growth hormone, specifically the 176-191 amino acid sequence with a stabilizing tyrosine addition at the N-terminus
Providers can: Support nutrient repletion during caloric restriction Address muscle loss with mitochondrial and protein support Optimize insulin signaling with botanicals and minerals Improve gut function impacted by slowed motility Guide patients transitioning off medications with sustainable protocols Natural Alternatives That Support GLP-1 Pathways Several natural compounds can influence similar metabolic mechanisms as GLP-1 agonists, often with additional benefits: Supplement Snapshot Providers can also highlight lifestyle biohacks known to boost natural GLP-1, such as exercise, circadian alignment, and prebiotic-rich foods
Unique Features: Semaglutide is the first GLP-1RA shown to reduce cardiovascular events in non-diabetic individuals, making it a notable choice for obesity management
Arch Facial Plast Surg 7:2731
Raj Rai, Sristi, Camelia Bhattacharyya, Anwita Sarkar, Surupa Chakraborty, Esha Sircar, Sreejita Dutta, et Rajib Sengupta